You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 15, 2025

CLINICAL TRIALS PROFILE FOR BARUSIBAN


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for Barusiban

Trial IDTitleStatusSponsorPhaseSummary
NCT00587327 ↗ Effect of Oxytocin and Vasopressin Antagonists on Uterine Contractions Completed Ferring Pharmaceuticals Phase 2 The main purpose of this clinical research trial was to evaluate the effects of barusiban and atosiban compared to placebo on luteal phase uterine contractions in oocyte donors supplemented with progesterone.
NCT01043120 ↗ Effect of Oxytocin Antagonist on Reduction of Uterine Contractions Completed Ferring Pharmaceuticals Phase 2 The main purpose of this clinical research trial was to evaluate the effects of barusiban compared to placebo on uterine contractions on luteal phase uterine contractions in oocyte donors supplemented with progesterone.
NCT01723982 ↗ Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions Completed Ferring Pharmaceuticals Phase 2 This trial investigates the effects of FE 200440 compared to placebo on implantation rate in women undergoing IVF/ICSI treatment
NCT02725736 ↗ Tocolytic Therapy for Preterm Labor in Multiple Gestation Unknown status Tel-Aviv Sourasky Medical Center Phase 3 To compare the tocolytic efficacy oxytocin receptor antagonist (Atosiban) with that of calcium channel blockers (Nifedipine) among women with multiple gestation who present with threatened preterm labor.
>Trial ID>Title>Status>Phase>Summary
Showing 1 to 4 of 4 entries

Clinical Trial Conditions for Barusiban

Condition Name

22110-0.200.20.40.60.811.21.41.61.822.2In Vitro Fertilisation (IVF) TreatmentIn Vitro Fertilisation (IVF) Treatment.InfertilityLabor Preterm Multiple[disabled in preview]
Condition Name
Intervention Trials
In Vitro Fertilisation (IVF) Treatment 2
In Vitro Fertilisation (IVF) Treatment. 2
Infertility 1
Labor Preterm Multiple 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

1110-0.100.10.20.30.40.50.60.70.80.911.1InfertilityPremature BirthObstetric Labor, Premature[disabled in preview]
Condition MeSH
Intervention Trials
Infertility 1
Premature Birth 1
Obstetric Labor, Premature 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Barusiban

Trials by Country

+
Trials by Country
Location Trials
Belgium 3
Spain 3
Czech Republic 3
Czechia 2
Australia 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Barusiban

Clinical Trial Phase

25.0%75.0%000.511.522.53Phase 3Phase 2[disabled in preview]
Clinical Trial Phase
Clinical Trial Phase Trials
Phase 3 1
Phase 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

75.0%25.0%000.511.522.53CompletedUnknown status[disabled in preview]
Clinical Trial Status
Clinical Trial Phase Trials
Completed 3
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Barusiban

Sponsor Name

trials0112233Ferring PharmaceuticalsTel-Aviv Sourasky Medical Center[disabled in preview]
Sponsor Name
Sponsor Trials
Ferring Pharmaceuticals 3
Tel-Aviv Sourasky Medical Center 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

75.0%25.0%000.511.522.53IndustryOther[disabled in preview]
Sponsor Type
Sponsor Trials
Industry 3
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.